<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(22)</volume><submitter>Ravi V</submitter><pubmed_abstract>Background Conventional right ventricular pacing (RVP) has been associated with an increased incidence of atrial fibrillation (AF). We sought to compare the occurrence of new-onset AF and assessed AF disease progression during long-term follow-up between His bundle pacing (HBP) and RVP. Methods and Results We included patients undergoing initial dual-chamber pacemaker implants at Rush University Medical Center between January 1, 2016, and June 30, 2019. A total of 360 patients were evaluated, and 225 patients (HBP, n=105; RVP, n=120) were included in the study. Among the 148 patients (HBP, n=72; RVP, n=76) with no history of AF, HBP demonstrated a lower risk of new-onset AF (adjusted hazard ratio [HR], 0.53; 95% CI, 0.28-0.99; &lt;i>P&lt;/i>=0.046) compared with traditional RVP. This benefit was observed with His or RVP burden exceeding 20% (HR, 0.29; 95% CI, 0.13-0.64; &lt;i>P&lt;/i>=0.002), ≥40% (HR, 0.31; &lt;i>P&lt;/i>=0.007), ≥60% (HR, 0.35; &lt;i>P&lt;/i>=0.015), and ≥80% (HR, 0.40; &lt;i>P&lt;/i>=0.038). There was no difference with His or RV pacing burden &lt;20% (HR, 0.613; 95% CI, 0.213-1.864; &lt;i>P&lt;/i>=0.404). In patients with a prior history of AF, there was no difference in AF progression (&lt;i>P&lt;/i>=0.715); however, in a subgroup of patients with a pacing burden ≥40%, HBP demonstrated a trend toward a lower risk of AF progression (HR, 0.19; 95% CI, 0.03-1.16; &lt;i>P&lt;/i>=0.072). Conclusions HBP demonstrated a lower risk of new-onset AF compared with RVP, which was primarily observed at a higher pacing burden.</pubmed_abstract><journal>Journal of the American Heart Association</journal><pagination>e018478</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7763709</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Development of New-Onset or Progressive Atrial Fibrillation in Patients With Permanent HIS Bundle Pacing Versus Right Ventricular Pacing: Results From the RUSH HBP Registry.</pubmed_title><pmcid>PMC7763709</pmcid><pubmed_authors>Larsen T</pubmed_authors><pubmed_authors>Vijayaraman P</pubmed_authors><pubmed_authors>Sharma PS</pubmed_authors><pubmed_authors>Ravi V</pubmed_authors><pubmed_authors>Trohman RG</pubmed_authors><pubmed_authors>Hanifin JL</pubmed_authors><pubmed_authors>Krishnan K</pubmed_authors><pubmed_authors>Ooms S</pubmed_authors><pubmed_authors>Beer D</pubmed_authors><pubmed_authors>Pietrasik GM</pubmed_authors><pubmed_authors>Huang HD</pubmed_authors><pubmed_authors>Ayub MT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of New-Onset or Progressive Atrial Fibrillation in Patients With Permanent HIS Bundle Pacing Versus Right Ventricular Pacing: Results From the RUSH HBP Registry.</name><description>Background Conventional right ventricular pacing (RVP) has been associated with an increased incidence of atrial fibrillation (AF). We sought to compare the occurrence of new-onset AF and assessed AF disease progression during long-term follow-up between His bundle pacing (HBP) and RVP. Methods and Results We included patients undergoing initial dual-chamber pacemaker implants at Rush University Medical Center between January 1, 2016, and June 30, 2019. A total of 360 patients were evaluated, and 225 patients (HBP, n=105; RVP, n=120) were included in the study. Among the 148 patients (HBP, n=72; RVP, n=76) with no history of AF, HBP demonstrated a lower risk of new-onset AF (adjusted hazard ratio [HR], 0.53; 95% CI, 0.28-0.99; &lt;i>P&lt;/i>=0.046) compared with traditional RVP. This benefit was observed with His or RVP burden exceeding 20% (HR, 0.29; 95% CI, 0.13-0.64; &lt;i>P&lt;/i>=0.002), ≥40% (HR, 0.31; &lt;i>P&lt;/i>=0.007), ≥60% (HR, 0.35; &lt;i>P&lt;/i>=0.015), and ≥80% (HR, 0.40; &lt;i>P&lt;/i>=0.038). There was no difference with His or RV pacing burden &lt;20% (HR, 0.613; 95% CI, 0.213-1.864; &lt;i>P&lt;/i>=0.404). In patients with a prior history of AF, there was no difference in AF progression (&lt;i>P&lt;/i>=0.715); however, in a subgroup of patients with a pacing burden ≥40%, HBP demonstrated a trend toward a lower risk of AF progression (HR, 0.19; 95% CI, 0.03-1.16; &lt;i>P&lt;/i>=0.072). Conclusions HBP demonstrated a lower risk of new-onset AF compared with RVP, which was primarily observed at a higher pacing burden.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Nov</publication><modification>2024-02-15T06:30:16.9Z</modification><creation>2021-02-20T16:54:53Z</creation></dates><accession>S-EPMC7763709</accession><cross_references><pubmed>33174509</pubmed><doi>10.1161/JAHA.120.018478</doi></cross_references></HashMap>